Chester County News and Community Website
MyChesCo is the perfect source for businesses in Philadelphia to stay informed and up-to-date with the latest business news. We provide essential information to help businesses grow, network, and hire. Our content is concise and objective, making it easy to stay informed and make well-informed decisions.
MyChesCo provides comprehensive Philadelphia business news, giving you the latest information and updates about local businesses. Our content features news about upcoming events, articles, and resources to help businesses grow and expand. We provide in-depth coverage of relevant topics and trends in the local business community, making it easy to stay informed and up-to-date.
MyChesCo also features resources to help businesses network and hire. Our content focuses on helping businesses connect with each other and build relationships. We also provide resources to help businesses find new hires and fill job openings. We make it easy for Philadelphia businesses to network and find the best talent to move their businesses forward.
Our content is comprehensive and accessible, making it easy for businesses in Philadelphia to find the information they need. Our content is updated regularly, giving you the most up-to-date news and information about local businesses. We provide concise and objective content, making it easy to stay informed and make well-informed decisions about your business.
PHILADELPHIA, PA — McAdam, a Philadelphia-based financial advisory firm, has been named one of America’s Top Financial Advisory Firms for 2026 by Newsweek, marking the second consecutive year it has …
McAdam Earns National Recognition Again With Spot on Newsweek’s 2026 Advisor List Read More
PHILADELPHIA, PA — Two well-known public companies with strong regional ties are under heightened legal scrutiny as shareholder investigations advance against Avantor, Inc. (NYSE: AVTR) and Five Below, Inc. (NASDAQ: …
Shareholder Scrutiny Intensifies as Avantor and Five Below Face Legal Challenges Read More
PHILADELPHIA, PA — Ethos Cannabis is deepening its commitment to criminal justice reform through a new partnership with the Last Prisoner Project (LPP), unveiling a limited-edition Clemency Kush vape product …
Ethos Cannabis Launches Clemency Kush in Multi-State Push for Cannabis Justice Read More
PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) has unveiled its first program targeting Type 1 diabetes, introducing an engineered cell therapy designed to restore natural insulin production without the …
Century Therapeutics Debuts Immune-Evasive Cell Therapy Aiming to Transform Type 1 Diabetes Read More
PHILADELPHIA, PA — 2X has launched what it calls the most comprehensive suite of 6sense services ever introduced, marking a major expansion in how enterprises can deploy, integrate, and scale …
2X Unveils Expansive 6sense Services Suite in Push to Redefine Revenue Tech Adoption Read More
PHILADELPHIA, PA — A new analysis from the Burning Glass Institute and the Alliance for Decision Education finds that decision-making skills have become one of the most sought-after and financially …
New Report Shows Decision-Making Skills Now Deliver Some of the Biggest Wage Premiums Read More
PHILADELPHIA, PA — The Weitz Firm, LLC announced an expansion of its personal injury services into North Philadelphia and Brewerytown, a move designed to meet rising demand for legal support …
Weitz Firm Expands Injury Services as Slip-and-Fall Claims Surge in North Philadelphia Read More
PHILADELPHIA, PA — pharosIQ unveiled a major upgrade to its atlasIQ Intelligence Engine, positioning the platform as a high-speed activation tool designed to help B2B marketers identify, engage, and convert …
AI Engine Promises Buyer Activation in Weeks — pharosIQ Pushes B2B Marketing Forward Read More
PHILADELPHIA, PA — Passage Bio, Inc. (Nasdaq: PASG) reported third-quarter financial results and outlined steady progress across its upliFT-D gene therapy program, positioning the company for critical regulatory and clinical …
Passage Bio Pushes Toward Key 2026 Milestones as Gene Therapy Program Accelerates Read More
PHILADELPHIA, PA — Vittoria Biotherapeutics, Inc. announced it will present interim clinical data from its first-in-human Phase 1 study of VIPER-101, a CD5-modulated autologous CAR-T therapy, at the upcoming American …
New CAR-T Data Could Upend T-Cell Lymphoma Care — Vittoria Prepares First Reveal Read More